Cost effectiveness analysis in health care: contraindications

This publication has 23 references indexed in Scilit:

• Twenty years of health care economic analysis in Spain: are we doing well?
  Health Economics, 2001
• The Cost Effectiveness of Combination Antiretroviral Therapy for HIV Disease
  New England Journal of Medicine, 2001
• Developing Guidance for Budget Impact Analysis
  PharmacoEconomics, 2001
• The influence of economic evaluation studies on decision making.
  Health Policy, 2000
• The Quality of Reporting in Published Cost-Utility Analyses, 1976–1997
  Annals of Internal Medicine, 2000
• Cost Effectiveness of Early Discharge after Uncomplicated Acute Myocardial Infarction
  New England Journal of Medicine, 2000
• Economics Notes: Types of economic evaluation
  BMJ, 1999
• Guidelines for authors and peer reviewers of economic submissions to the BMJ
  BMJ, 1996
• Cost Effectiveness of Thrombolytic Therapy with Tissue Plasminogen Activator as Compared with Streptokinase for Acute Myocardial Infarction
  New England Journal of Medicine, 1995
• Foundations of Cost-Effectiveness Analysis for Health and Medical Practices
  New England Journal of Medicine, 1977